← Browse by Condition
Medical Condition

mismatch repair deficient or msi high solid tumors

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT07262619 Phase 1, Phase 2
Recruiting

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

Enrollment
160 pts
Location
United States, Austr...
Sponsor
Eikon Therapeutics
View Trial →